AWM
ZVRA icon

Activest Wealth Management’s Zevra Therapeutics ZVRA Stock Holding History

Activest Wealth Management’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26K Hold
1,815
– – 0.01% 389
2026
Q1 		$16.9K Hold
1,815
– – ﹤0.01% 568
2025
Q4 		$16.3K Hold
1,815
– – ﹤0.01% 558
2025
Q3 		$17.3K Hold
1,815
– – ﹤0.01% 405
2025
Q2 		$16K Hold
1,815
– – ﹤0.01% 360
2025
Q1 		$13.6K Hold
1,815
– – ﹤0.01% 346
2024
Q4 		$15.1K Hold
1,815
– – ﹤0.01% 276
2024
Q3 		$12.6K Hold
1,815
– – ﹤0.01% 296
2024
Q2 		$8.89K Buy
+1,815
New +$8.6K ﹤0.01% 306

Other funds holding ZVRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Activest Wealth Management's ZVRA Position: Q2 2026 in Review

Activest Wealth Management held its Zevra Therapeutics (ZVRA) position steady in Q2 2026 at 1,815 shares worth $26K. The position accounts for 0.01% of the portfolio, ranked #389.

Activest Wealth Management first reported a position in ZVRA in Q2 2024 and has held it in 9 quarters since. 157 funds tracked by Wall St. Rank hold ZVRA as of Q2 2026.

  • Activest Wealth Management held 1,815 shares of Zevra Therapeutics worth $26K as of Q2 2026.
  • Activest Wealth Management left its Zevra Therapeutics share count unchanged in Q2 2026.
  • Zevra Therapeutics made up 0.01% of Activest Wealth Management's portfolio in Q2 2026, its #389 holding.
  • Activest Wealth Management first reported a position in Zevra Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • 157 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.